SAGE: Severe ARDS: Generating Evidence
Study Details
Study Description
Brief Summary
An assessment of early management of moderate-severe ARDS in the United States, including ventilator management and use of rescue therapy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Approximately one-quarter of ARDS patients develop severe hypoxemia, which has been associated with mortality rates approximating 40-50%. The majority have been described to present with severe disease at baseline, suggesting an opportunity for early intervention. In addition, use of evidence-based practices in severe ARDS is highly variable and inconsistent; use of unproven treatment modalities is also frequently seen. Given the variability in treatment practices in severe ARDS, an understanding of the patient-level and institutional-level factors contributing to differences in therapeutic approach is needed in order to improve the quality and consistency of care given to these high-risk patients. SAGE is a multicenter, observational cohort study examining the patient-level and institutional characteristics associated with variability in management of patients with moderate to severe ARDS, factors associated with survival or need for adjuvant therapy, and variability in ventilator management of patients on extracorporeal membrane oxygenation. Findings from this observational study can subsequently be used to inform future interventional trial development.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Moderate-Severe ARDS All adults admitted to participating ICUs with study-defined moderate-to-severe ARDS. |
Outcome Measures
Primary Outcome Measures
- Hospital Mortality [28 Days]
- Use of Adjunctive Therapy [28 Days]
Secondary Outcome Measures
- Ventilator-Free Days [28 Days]
- ICU-Free Days [28 Days]
- Organ Failure [7 Days]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age > 18 years
-
Patients with acute respiratory failure requiring invasive mechanical ventilation via an endotracheal tube or tracheostomy with current or planned admission to the ICU
-
Moderate-severe ARDS as defined by fulfillment of all of the following within 48 hours:
-
Bilateral opacities detected on chest radiograph or CT, not fully explained by effusions, lung collapse, or nodules
-
Respiratory failure not fully explained by cardiac failure or fluid overload
-
PaO2/FiO2 ratio < 150 with a minimum of 5 cmH20 PEEP
Exclusion Criteria:
There are no exclusion criteria.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Arizona | Tucson | Arizona | United States | 85721 |
2 | Los Angeles County + University of Southern California Medical Center | Los Angeles | California | United States | 90033 |
3 | University of California, Los Angeles | Los Angeles | California | United States | 90095 |
4 | Mayo Clinic | Jacksonville | Florida | United States | 32224 |
5 | Emory University | Atlanta | Georgia | United States | 30322 |
6 | University of Kentucky Medical Center | Lexington | Kentucky | United States | 40536 |
7 | Saint Agnes Hospital | Baltimore | Maryland | United States | 21229 |
8 | Johns Hopkins University | Baltimore | Maryland | United States | 21287 |
9 | Brigham and Women's Hospital | Boston | Massachusetts | United States | 02115 |
10 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
11 | Baystate Medical Center | Springfield | Massachusetts | United States | 01199 |
12 | University of Michigan Medical Center | Ann Arbor | Michigan | United States | 48109 |
13 | Saint Joseph Mercy Ann Arbor | Ypsilanti | Michigan | United States | 48197 |
14 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
15 | Regions Hospital | Saint Paul | Minnesota | United States | 55101 |
16 | Montefiore Medical Center | Bronx | New York | United States | 10467 |
17 | Northwell Health | Manhasset | New York | United States | 11030 |
18 | Columbia University Medical Center | New York | New York | United States | 10032 |
19 | Duke University Medical Center | Durham | North Carolina | United States | 27710 |
20 | East Carolina University | Greenville | North Carolina | United States | 27834 |
21 | University of Cincinnati Medical Center | Cincinnati | Ohio | United States | 45219 |
22 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
23 | Ohio State University Medical Center | Columbus | Ohio | United States | 43210 |
24 | Oregan Health and Science University Hospital | Portland | Oregon | United States | 97239 |
25 | Temple University Hospital | Philadelphia | Pennsylvania | United States | 19140 |
26 | Intermountain Medical Center | Murray | Utah | United States | 84107 |
27 | University of Utah Hospital | Salt Lake City | Utah | United States | 84132 |
28 | Harborview Medical Center | Seattle | Washington | United States | 98104 |
Sponsors and Collaborators
- Montefiore Medical Center
- University of Michigan
- Duke University
- University of California, Los Angeles
Investigators
- Principal Investigator: Nida Qadir, MD, Montefiore Medical Center
- Principal Investigator: Pauline Park, MD, University of Michigan
- Principal Investigator: Raquel Bartz, MD, Duke University
- Principal Investigator: Michelle N Gong, MD, Montefiore Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2016-6757